These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32919113)

  • 1. Structure-activity relationship studies and bioactivity evaluation of 1,2,3-triazole containing analogues as a selective sphingosine kinase-2 inhibitors.
    Tangadanchu VKR; Jiang H; Yu Y; Graham TJA; Liu H; Rogers BE; Gropler R; Perlmutter J; Tu Z
    Eur J Med Chem; 2020 Nov; 206():112713. PubMed ID: 32919113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors.
    Congdon M; Fritzemeier RG; Kharel Y; Brown AM; Serbulea V; Bevan DR; Lynch KR; Santos WL
    Eur J Med Chem; 2021 Feb; 212():113121. PubMed ID: 33445156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents.
    Corvino A; Rosa R; Incisivo GM; Fiorino F; Frecentese F; Magli E; Perissutti E; Saccone I; Santagada V; Cirino G; Riemma MA; Temussi PA; Ciciola P; Bianco R; Caliendo G; Roviezzo F; Severino B
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.
    Raje MR; Knott K; Kharel Y; Bissel P; Lynch KR; Santos WL
    Bioorg Med Chem; 2012 Jan; 20(1):183-94. PubMed ID: 22137932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine kinase 2 inhibitor SG-12 induces apoptosis via phosphorylation by sphingosine kinase 2.
    Hara-Yokoyama M; Terasawa K; Ichinose S; Watanabe A; Podyma-Inoue KA; Akiyoshi K; Igarashi Y; Yanagishita M
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2220-4. PubMed ID: 23434415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorinated triazole-containing sphingosine analogues. Syntheses and in vitro evaluation as SPHK inhibitors.
    Escudero-Casao M; Cardona A; Beltrán-Debón R; Díaz Y; Matheu MI; Castillón S
    Org Biomol Chem; 2018 Oct; 16(39):7230-7235. PubMed ID: 30255187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing 2-dimethylhydrazino-2-alkyl alkynyl sphingosine derivatives as sphingosine kinase 2 inhibitors: Some hints on the structural basis for selective inhibition.
    Corro-Morón M; Granell A; Ivanova V; Domingo E; Beltrán-Debón R; Barril X; Sanz MJ; Matheu MI; Castillón S; Díaz Y
    Bioorg Chem; 2022 Apr; 121():105668. PubMed ID: 35219046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.
    Congdon MD; Childress ES; Patwardhan NN; Gumkowski J; Morris EA; Kharel Y; Lynch KR; Santos WL
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4956-4960. PubMed ID: 25862200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor.
    Khairat SHM; Omar MA; Ragab FAF; Roy S; Turab Naqvi AA; Abdelsamie AS; Hirsch AKH; Galal SA; Hassan MI; El Diwani HI
    Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100080. PubMed ID: 34128259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 2-epi-jaspine B analogs as selective sphingosine kinase 1 inhibitors.
    Yang H; Li Y; Chai H; Yakura T; Liu B; Yao Q
    Bioorg Chem; 2020 May; 98():103369. PubMed ID: 31703810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.
    Patwardhan NN; Morris EA; Kharel Y; Raje MR; Gao M; Tomsig JL; Lynch KR; Santos WL
    J Med Chem; 2015 Feb; 58(4):1879-1899. PubMed ID: 25643074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases.
    Billich A; Bornancin F; Dévay P; Mechtcheriakova D; Urtz N; Baumruker T
    J Biol Chem; 2003 Nov; 278(48):47408-15. PubMed ID: 13129923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Characterization of Structural Distinctions between Isoforms of Human and Mouse Sphingosine Kinases for Accelerating Drug Discovery.
    Worrell BL; Brown AM; Santos WL; Bevan DR
    J Chem Inf Model; 2019 May; 59(5):2339-2351. PubMed ID: 30844267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity.
    Sibley CD; Morris EA; Kharel Y; Brown AM; Huang T; Bevan DR; Lynch KR; Santos WL
    J Med Chem; 2020 Feb; 63(3):1178-1198. PubMed ID: 31895563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
    Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
    Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
    Lynch KR; Thorpe SB; Santos WL
    Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
    Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
    Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of SphK inhibitors using crystal structures aided by computer.
    Ding T; Zhi Y; Xie W; Yao Q; Liu B
    Eur J Med Chem; 2021 Mar; 213():113164. PubMed ID: 33454547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
    El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.